You are herePeptic Ulcer Disease and its Screening

Peptic Ulcer Disease and its Screening


Disruption of Gastric Mucosal Barrier
Two mechanisms that protect
• Mucus forms a layer that entraps or slows diffusion of hydrogen ions across mucosal barrier
• Bicarbonate is secreted
• Neutralizes HCl acid in lumen of GI tract
• Vagal nerve stimulation results in hypersecretion of HCl acid
• HCl acid can alter mucosal barrier
• Duodenal ulcers are associated with acid

Peptic Ulcer Disease Clinical Manifestations
• Common to have no pain or other symptoms
• Gastric and duodenal mucosa not rich in sensory pain fibers
• Duodenal ulcer pain
• Burning, cramplike
• Gastric ulcer pain
• Burning, gaseous
• 3 major complications
• Hemorrhage
• Perforation
• Gastric outlet obstruction

Peptic Ulcer DiseaseHemorrhage
• Most common complication of peptic ulcer disease
• Develops from erosion of
• Granulation tissue found at base of ulcer during healing
• Ulcer through a major blood vessel

• Occurs when ulcer penetrates serosal surface
• Spillage of their gastric or duodenal contents into peritoneal cavity
• Size of perforation directly proportional to length of time patient has had ulcer
• Sudden, dramatic onset

Peptic Ulcer Disease Gastric Outlet Obstruction
• Ulcers located in antrum and prepyloric and pyloric areas of stomach
• Duodenum can predispose to gastric outlet obstruction
• contractile force needed to empty stomach results in hypertrophy of stomach wall
• Peptic Ulcer DiseaseGastric Outlet Obstruction
• After longstanding obstruction stomach enters decompensated phase
• Results in dilation and atony
• Obstruction is not totally due to fibrous scar tissue
• Active ulcer formation is associated with edema, inflammation, pylorospasm
• All contribute to narrowing of pylorus
• Usually has a history of ulcer pain
• Short duration or absence of pain indicative of a malignant obstruction
• Vomiting is common
• Constipation is a common complaint
• Dehydration, lack of roughage in diet
• May show swelling in upper abdomen

Peptic Ulcer Disease Diagnostic Studies
• Endoscopy procedure most often used
• Determines degree of ulcer healing after treatment
• Tissue specimens can be obtained to identify H. pyloriand to rule out gastric cancer
• Tests for H. pylori
• Noninvasive tests
• Serum or whole blood antibody tests
• Immunoglobin G (IgG)
• Urea breath test
• Invasive tests
• Biopsy of stomach
• Rapid urease test
• Barium contrast studies
• Widely used
• X-ray studies
• Ineffective in differentiating a peptic ulcer from a malignant tumor
• Gastric analysis
• Identifying a possible gastrinoma
• Determining degree of gastric hyperacidity
• Evaluating results of therapy
• Laboratory analysis
• CBC
• Urinalysis
• Liver enzyme studies
• Serum amylase determination
• Stool examination

Peptic Ulcer Disease Collaborative Care
Medical regimen consists of
• Adequate rest
• Dietary modification
• Drug therapy
• Elimination of smoking
• Long-term follow-up care
• Aim of treatment program
• degree of gastric acidity
• Enhance mucosal defense mechanisms
• Minimize harmful effects on mucosa
• Generally treated in ambulatory care clinics
• Requires many weeks of therapy
• Pain disappears after 3 to 6 days

Healing may take 3 to 9 weeks

• Should be assessed by means of x-rays or endoscopic examination
Moderation in daily activity is essential
NSAIDs that are COX-2 inhibitors are used

Peptic Ulcer Disease Drug Therapy
Includes use of
Antacids
H2R blockers
PPIs
Antibiotics
Anticholinergics
Cytoproctective therapy

Recurrence of peptic ulcer is frequent
Interruption or discontinuation of therapy can have detrimental results
No drugs, unless prescribed by health care provider, should be taken
Ulcerogenic effect

Histamine-2 receptor blocks (H2R blockers)
• Used to manage peptic ulcer disease
• Block action of histamine on H2receptors
• Decrease HCl acid secretion
• Decrease conversion of pepsinogen to pepsin
• Increase ulcer healing

Proton pump inhibitors (PPI)
• Block ATPase enzyme that is important for secretion of HCl acid

Antibiotic therapy
• Eradicate H. pyloriinfection
• No single agents have been effective in eliminating H. pylori

Antacids
• Used as adjunct therapy for peptic ulcer disease
• Increase gastric pH by neutralizing acid

Anticholinergic drugs
• Occasionally ordered for treatment
• Decrease cholinergic stimulation of HCl acid

Cytoprotective drug therapy
• Used for short-term treatment of ulcers
• Tricyclic antidepressants
• Serotonin reuptake inhibitors

NOW YOU CAN ALSO PUBLISH YOUR ARTICLE ONLINE.

SUBMIT YOUR ARTICLE/PROJECT AT articles@pharmatutor.org

Subscribe to Pharmatutor Job Alerts by Email

FIND OUT MORE ARTICLES AT OUR DATABASE


RADHESHYAM BHATI (not verified)
COMMENT

NICE ARTICLE VERY USEFULL

Anonymous
Oyon

Nice article. Very detailed and informative. I have also written an article on peptic ulcer disease.

FIND MORE ARTICLES

Subscribe to RSS headline updates from:
Powered by FeedBurner